Search results for "Diabetes"
ACP: Best practice for diabetes is diet, then metformin, then any second drug
New diabetes guidelines from the American College of Physicians recommend prescribing a drug when lifestyle changes don't lower hyperglycemia. Specifically, start with metformin first and then add any second oral agent.
https://immattersacp.org/weekly/archives/2012/02/07/4.htm
7 Feb 2012
Diabetes education programs show mixed results
Educational programs for patients with uncontrolled diabetes showed some success but overall had mixed results in three recent trials.
https://immattersacp.org/weekly/archives/2011/10/18/4.htm
18 Oct 2011
Updated warnings on fluoroquinolones, new diabetes drug
This column reviews a warning on fluoroquinolones with a risk of disabling and potentially permanent side effects, as well as approval of an injection to improve glycemic control in adults with type 2 diabetes.
https://immattersacp.org/archives/2016/10/fda.htm
1 Oct 2016
MKSAP Quiz: routine follow-up visit for diabetes and hyperlipidemia
A 59-year-old woman is evaluated during a routine follow-up visit. She was recently diagnosed with type 2 diabetes mellitus and hyperlipidemia. She feels well. Medications are metformin, atorvastatin, and aspirin. Following a physical exam and lab results, what is the most appropriate diagnostic test to perform next?
https://immattersacp.org/weekly/archives/2014/03/11/3.htm
11 Mar 2014
Intensive blood pressure targets didn't reduce mortality in type 2 diabetes
Intensive hypertension treatment slightly reduced the risk of stroke in type 2 diabetics, but had no effect on mortality or myocardial infarction, a new review found.
https://immattersacp.org/weekly/archives/2012/08/14/6.htm
14 Aug 2012
Latest updates on ACP's priorities, initiatives
ACP Spotlight offers readers a look at ACP's current top priorities and initiatives, as well as highlights from our e-newsletter, I.M. Matters Weekly from ACP.
https://immattersacp.org/archives/2024/04/latest-updates-on-acps-priorities-initiatives.htm
1 Apr 2024
Large review compares benefits, harms of drugs to treat type 2 diabetes
High-certainty evidence indicated that sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists reduce all-cause death, while finerenone probably also reduced mortality based on moderate-certainty evidence.
https://immattersacp.org/weekly/archives/2023/04/18/4.htm
18 Apr 2023
Potential problematic prescribing in older women
Prescription of systemic estrogen therapy after menopause could be a red flag for use of other medications linked to dementia.
https://immattersacp.org/archives/2024/04/potential-problematic-prescribing-in-older-women.htm
1 Apr 2024
Some newer diabetes drugs may help decrease risk of COPD exacerbation
A cohort study in the United Kingdom found that chronic obstructive pulmonary disease (COPD) exacerbations were less common in patients with type 2 diabetes and COPD taking glucagon-like peptide-1 receptor agonists or sodium-glucose cotransporter-2 inhibitors versus sulfonylureas.
https://immattersacp.org/weekly/archives/2022/11/08/4.htm
8 Nov 2022
Tirzepatide for weight management, at-home STI tests
This column reviews recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2024/01/tirzepatide-for-weight-management-at-home-sti-tests.htm
1 Jan 2024